Selected research
Market Structure
Global Inhalation Preparation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Inhalation Preparation market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Inhalation Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Inhalation Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Inhalation Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Inhalation Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Inhalation Preparation include GSK, Boehringer-Ingelheim, AstraZeneca, Daphne Pharmaceutical, Hengrui Medicine, Joincare Pharmaceutical, Purity Pharmaceutical, Jewim Pharmaceutical and Sphsine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Inhalation Preparation market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Inhalation Preparation and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Inhalation Preparation sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhalation Preparation market size, projected growth trends, production technologies, key applications, and end-use industries.
Inhalation Preparation Segment by Company
GSK
Boehringer-Ingelheim
AstraZeneca
Daphne Pharmaceutical
Hengrui Medicine
Joincare Pharmaceutical
Purity Pharmaceutical
Jewim Pharmaceutical
Sphsine
Xianju Pharmaceutical
CF PharmTech
CTTQ
Inhalation Preparation Segment by Type
Nebules Inhalation Solution (NEB)
Metered Dose Inhalers (MDI)
Spary
Dry Powder Inhalation (DPI)
Inhalation Preparation Segment by Application
Pulmonary Hypertension Treatment
COPD
Inhalation Anesthesia
Asthma
Others
Inhalation Preparation Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Preparation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inhalation Preparation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Preparation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Inhalation Preparation market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inhalation Preparation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Inhalation Preparation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Inhalation Preparation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Nebules Inhalation Solution (NEB)
- Metered Dose Inhalers (MDI)
- Spary
- Dry Powder Inhalation (DPI)
Applications
- Pulmonary Hypertension Treatment
- COPD
- Inhalation Anesthesia
- Asthma
- Others
Companies covered
- GSK
- Boehringer-Ingelheim
- AstraZeneca
- Daphne Pharmaceutical
- Hengrui Medicine
- Joincare Pharmaceutical
- Purity Pharmaceutical
- Jewim Pharmaceutical
- Sphsine
- Xianju Pharmaceutical
- CF PharmTech
- CTTQ
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Inhalation Preparation Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Inhalation Preparation Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Inhalation Preparation Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Inhalation Preparation Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Inhalation Preparation Market Dynamics
- 2.1 Inhalation Preparation Industry Trends
- 2.2 Inhalation Preparation Industry Drivers
- 2.3 Inhalation Preparation Industry Opportunities and Challenges
- 2.4 Inhalation Preparation Industry Restraints
3 Inhalation Preparation Market by Manufacturers
- 3.1 Global Inhalation Preparation Revenue by Manufacturers (2021-2026)
- 3.2 Global Inhalation Preparation Sales by Manufacturers (2021-2026)
- 3.3 Global Inhalation Preparation Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Inhalation Preparation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Inhalation Preparation Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Inhalation Preparation Manufacturers, Product Type & Application
- 3.7 Global Inhalation Preparation Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Inhalation Preparation Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Inhalation Preparation Players Market Share by Revenue in 2025
- 3.8.3 2025 Inhalation Preparation Tier 1, Tier 2, and Tier 3
4 Inhalation Preparation Market by Type
- 4.1 Inhalation Preparation Type Introduction
- 4.1.1 Nebules Inhalation Solution (NEB)
- 4.1.2 Metered Dose Inhalers (MDI)
- 4.1.3 Spary
- 4.1.4 Dry Powder Inhalation (DPI)
- 4.2 Global Inhalation Preparation Sales by Type
- 4.2.1 Global Inhalation Preparation Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Inhalation Preparation Sales by Type (2021-2032)
- 4.2.3 Global Inhalation Preparation Sales Market Share by Type (2021-2032)
- 4.3 Global Inhalation Preparation Revenue by Type
- 4.3.1 Global Inhalation Preparation Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Inhalation Preparation Revenue by Type (2021-2032)
- 4.3.3 Global Inhalation Preparation Revenue Market Share by Type (2021-2032)
5 Inhalation Preparation Market by Application
- 5.1 Inhalation Preparation Application Introduction
- 5.1.1 Pulmonary Hypertension Treatment
- 5.1.2 COPD
- 5.1.3 Inhalation Anesthesia
- 5.1.4 Asthma
- 5.1.5 Others
- 5.2 Global Inhalation Preparation Sales by Application
- 5.2.1 Global Inhalation Preparation Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Inhalation Preparation Sales by Application (2021-2032)
- 5.2.3 Global Inhalation Preparation Sales Market Share by Application (2021-2032)
- 5.3 Global Inhalation Preparation Revenue by Application
- 5.3.1 Global Inhalation Preparation Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Inhalation Preparation Revenue by Application (2021-2032)
- 5.3.3 Global Inhalation Preparation Revenue Market Share by Application (2021-2032)
6 Global Inhalation Preparation Sales by Region
- 6.1 Global Inhalation Preparation Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Inhalation Preparation Sales by Region (2021-2032)
- 6.2.1 Global Inhalation Preparation Sales by Region (2021-2026)
- 6.2.2 Global Inhalation Preparation Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Inhalation Preparation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Inhalation Preparation Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Inhalation Preparation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Inhalation Preparation Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Inhalation Preparation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Inhalation Preparation Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Inhalation Preparation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Inhalation Preparation Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Inhalation Preparation Revenue by Region
- 7.1 Global Inhalation Preparation Revenue by Region
- 7.1.1 Global Inhalation Preparation Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Inhalation Preparation Revenue by Region (2021-2026)
- 7.1.3 Global Inhalation Preparation Revenue by Region (2027-2032)
- 7.1.4 Global Inhalation Preparation Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Inhalation Preparation Revenue (2021-2032)
- 7.2.2 North America Inhalation Preparation Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Inhalation Preparation Revenue (2021-2032)
- 7.3.2 Europe Inhalation Preparation Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Inhalation Preparation Revenue (2021-2032)
- 7.4.2 Asia-Pacific Inhalation Preparation Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Inhalation Preparation Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Inhalation Preparation Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 GSK
- 8.1.1 GSK Company Information
- 8.1.2 GSK Business Overview
- 8.1.3 GSK Inhalation Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 GSK Inhalation Preparation Product Portfolio
- 8.1.5 GSK Recent Developments
- 8.2 Boehringer-Ingelheim
- 8.2.1 Boehringer-Ingelheim Company Information
- 8.2.2 Boehringer-Ingelheim Business Overview
- 8.2.3 Boehringer-Ingelheim Inhalation Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Boehringer-Ingelheim Inhalation Preparation Product Portfolio
- 8.2.5 Boehringer-Ingelheim Recent Developments
- 8.3 AstraZeneca
- 8.3.1 AstraZeneca Company Information
- 8.3.2 AstraZeneca Business Overview
- 8.3.3 AstraZeneca Inhalation Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 AstraZeneca Inhalation Preparation Product Portfolio
- 8.3.5 AstraZeneca Recent Developments
- 8.4 Daphne Pharmaceutical
- 8.4.1 Daphne Pharmaceutical Company Information
- 8.4.2 Daphne Pharmaceutical Business Overview
- 8.4.3 Daphne Pharmaceutical Inhalation Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Daphne Pharmaceutical Inhalation Preparation Product Portfolio
- 8.4.5 Daphne Pharmaceutical Recent Developments
- 8.5 Hengrui Medicine
- 8.5.1 Hengrui Medicine Company Information
- 8.5.2 Hengrui Medicine Business Overview
- 8.5.3 Hengrui Medicine Inhalation Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Hengrui Medicine Inhalation Preparation Product Portfolio
- 8.5.5 Hengrui Medicine Recent Developments
- 8.6 Joincare Pharmaceutical
- 8.6.1 Joincare Pharmaceutical Company Information
- 8.6.2 Joincare Pharmaceutical Business Overview
- 8.6.3 Joincare Pharmaceutical Inhalation Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Joincare Pharmaceutical Inhalation Preparation Product Portfolio
- 8.6.5 Joincare Pharmaceutical Recent Developments
- 8.7 Purity Pharmaceutical
- 8.7.1 Purity Pharmaceutical Company Information
- 8.7.2 Purity Pharmaceutical Business Overview
- 8.7.3 Purity Pharmaceutical Inhalation Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Purity Pharmaceutical Inhalation Preparation Product Portfolio
- 8.7.5 Purity Pharmaceutical Recent Developments
- 8.8 Jewim Pharmaceutical
- 8.8.1 Jewim Pharmaceutical Company Information
- 8.8.2 Jewim Pharmaceutical Business Overview
- 8.8.3 Jewim Pharmaceutical Inhalation Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Jewim Pharmaceutical Inhalation Preparation Product Portfolio
- 8.8.5 Jewim Pharmaceutical Recent Developments
- 8.9 Sphsine
- 8.9.1 Sphsine Company Information
- 8.9.2 Sphsine Business Overview
- 8.9.3 Sphsine Inhalation Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Sphsine Inhalation Preparation Product Portfolio
- 8.9.5 Sphsine Recent Developments
- 8.10 Xianju Pharmaceutical
- 8.10.1 Xianju Pharmaceutical Company Information
- 8.10.2 Xianju Pharmaceutical Business Overview
- 8.10.3 Xianju Pharmaceutical Inhalation Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Xianju Pharmaceutical Inhalation Preparation Product Portfolio
- 8.10.5 Xianju Pharmaceutical Recent Developments
- 8.11 CF PharmTech
- 8.11.1 CF PharmTech Company Information
- 8.11.2 CF PharmTech Business Overview
- 8.11.3 CF PharmTech Inhalation Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 CF PharmTech Inhalation Preparation Product Portfolio
- 8.11.5 CF PharmTech Recent Developments
- 8.12 CTTQ
- 8.12.1 CTTQ Company Information
- 8.12.2 CTTQ Business Overview
- 8.12.3 CTTQ Inhalation Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 CTTQ Inhalation Preparation Product Portfolio
- 8.12.5 CTTQ Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Inhalation Preparation Value Chain Analysis
- 9.1.1 Inhalation Preparation Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Inhalation Preparation Production Mode & Process
- 9.2 Inhalation Preparation Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Inhalation Preparation Distributors
- 9.2.3 Inhalation Preparation Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst